Get the Stockscreener App
4.63
6.28%
-0.31
Pre-market:
4.64
0.010
+0.22%
Shattuck Labs Inc stock is traded at $4.63, with a volume of 945.67K.
It is down -6.28% in the last 24 hours and down -26.04% over the past month.
Shattuck Labs Inc is a biotechnology company specializing in the development of potential treatments for inflammatory and immune-mediated diseases. It is developing a potentially first-in-class antibody for the treatment of inflammatory bowel disease (IBD) and other inflammatory and immune-mediated diseases. The company's expertise in protein engineering and the development of novel tumor necrosis factor (TNF) receptor therapeutics comes together in its main program, SL-325, which has the potential to be a first-in-class death receptor 3 (DR3) antagonist antibody. In addition, the company is developing SL-425, a half-life extended version of SL-325, and multiple other preclinical DR3-based bispecific antibodies, for the treatment of patients with IBD.
See More
Previous Close:
$4.94
Open:
$4.97
24h Volume:
945.67K
Relative Volume:
1.41
Market Cap:
$442.20M
Revenue:
$1,000.00K
Net Income/Loss:
$-48.81M
P/E Ratio:
-5.9842
EPS:
-0.7737
Net Cash Flow:
$-39.95M
1W Performance:
+18.72%
1M Performance:
-26.04%
6M Performance:
+51.31%
1Y Performance:
+358.42%
1-Day Range:
$4.61
$5.1023
1-Week Range:
$3.97
$5.1023
52-Week Range:
$0.712
$8.33
Shattuck Labs Inc Stock (STTK) Company Profile
Name
Shattuck Labs Inc
Sector
Industry
Phone
512-900-4690
Address
500 W. 5TH STREET, AUSTIN
Compare STTK vs VRTX, REGN, ARGX, ALNY, RVMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
STTK
Shattuck Labs Inc
|
4.63 | 442.20M | 1,000.00K | -48.81M | -39.95M | -0.7737 |
VRTX
Vertex Pharmaceuticals Inc
|
450.46 | 114.33B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
614.98 | 64.47B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
884.20 | 54.99B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
287.80 | 38.42B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
160.06 | 34.03B | 742.00K | -1.37B | -1.07B | -7.0731 |
Shattuck Labs Inc Stock (STTK) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-27-26 | Initiated | Cantor Fitzgerald | Overweight |
| Mar-06-26 | Resumed | Needham | Buy |
| Jan-28-26 | Initiated | Piper Sandler | Overweight |
| Dec-01-25 | Upgrade | H.C. Wainwright | Neutral → Buy |
| Sep-08-25 | Initiated | Wedbush | Outperform |
| Mar-17-25 | Initiated | Leerink Partners | Outperform |
| Oct-02-24 | Downgrade | Citigroup | Buy → Neutral |
| Oct-02-24 | Downgrade | Needham | Buy → Hold |
| Oct-01-24 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Jun-17-24 | Downgrade | BTIG Research | Buy → Neutral |
| Aug-31-22 | Initiated | BTIG Research | Buy |
| Jun-01-22 | Initiated | Citigroup | Buy |
| May-02-22 | Initiated | H.C. Wainwright | Buy |
| Apr-14-21 | Initiated | Berenberg | Buy |
| Jan-11-21 | Initiated | Evercore ISI | Outperform |
| Nov-03-20 | Initiated | Citigroup | Buy |
| Nov-03-20 | Initiated | Cowen | Outperform |
| Nov-03-20 | Initiated | Needham | Buy |
View All
Shattuck Labs Inc Stock (STTK) Latest News
OrbiMed funds tied to Shattuck Labs (STTK) buy 1.25M pre-funded warrants - Stock Titan
OrbiMed funds add STTK pre-funded warrants in June 2026 stock offering - Stock Titan
[SCHEDULE 13D/A] Shattuck Labs, Inc. Amended Major Shareholder Report - Stock Titan
Top iBio (IBIO) Competitors 2026 - MarketBeat
Shattuck Labs drops 6%, prices $75M share raise at $4 per share - MSN
Shattuck Labs Stock (US8124231002): Valuation picture for this small-cap biotech - AD HOC NEWS
Insider Buying: Clay Siegall Acquires 62,500 Shares of Shattuck Labs Inc (STTK) - GuruFocus
Redmile funds detail 9.9% Shattuck Labs (STTK) stake and warrant activity - Stock Titan
Shattuck Labs (STTK) director Clay Siegall buys 62,500 shares at $4 - Stock Titan
Shattuck Labs secures $54.9M from warrant exercises, extends cash runway into 2029 - MSN
Shattuck Labs Launches $4.00 Underwritten Offering; 10.9M Shares, 7.9M Pre-Funded Warrants - TradingView
Shattuck Labs (NASDAQ: STTK) launches stock and pre-funded warrant offering at $4.00 - Stock Titan
Shattuck Labs (NASDAQ: STTK) raises ~$70.5M via equity and pre-funded warrants - Stock Titan
Latham & Watkins Advises on Shattuck Labs’ US$75 Million Public Offering - Legal Desire Media and Insights
STTK News | SHATTUCK LABS INC (NASDAQ:STTK) - ChartMill
Shattuck Labs launches proposed public offering of common stock - MSN
Shattuck Labs (STTK) Announces $75 Million Public Offering - GuruFocus
What's Going On With Shattuck Labs Stock Wednesday? - Benzinga
STTK Secures Financing with Offering Range Between $4.00 and $4. - GuruFocus
Shattuck Labs: 'Hold' On Phase 1 SL-325 Data And Next Stage Of Development (NASDAQ:STTK) - Seeking Alpha
Shattuck Labs Prices $75 Million Public Offering - marketscreener.com
Shattuck Labs, Inc. Announces Pricing of $75 Million Public Offering - Investing News Network
Shattuck Labs prices $75M public offering to fund biotech development. - Pluang
Shattuck Labs prices $75M public offering at $4 per share - Investing.com India
Shattuck Labs prices $75M public offering at $4 per share By Investing.com - Investing.com Australia
Shattuck Labs Prices Prefunded Warrants to Purchase Up to 7.9M Shares at Public Offering Price of $3.999 Each >STTK - Moomoo
Biotech Shattuck Labs sets terms for $75M stock, warrant sale - Stock Titan
Shattuck Labs, Inc. Announces Pricing Of $75 Million Public Offering At $4 Per Share - TradingView
Shattuck Labs, Inc. Announces Pricing of $75 Million Public Offering - Benzinga
STTK Secures Joint Book Runners for Upcoming Offering - GuruFocus
OrbiMed funds shift into pre-funded STTK warrants in Shattuck Labs (STTK) Form 4 - Stock Titan
Shattuck Labs stock falls on public offering announcement By Investing.com - Investing.com Nigeria
Shattuck Labs, Inc. Announces Proposed Public Offering - Investing News Network
Shattuck Labs commences public offering of common stock - Investing.com
Shattuck Labs commences public offering of common stock By Investing.com - Investing.com Nigeria
Shattuck Labs (STTK) offers common stock and pre-funded warrants; warrants exercise boosts cash - Stock Titan
Shattuck Labs stock falls on public offering announcement - Investing.com UK
Shattuck Labs posts positive Phase 1 SL-325 data; warrants exercise to fund operations into 2029 - TradingView
Shattuck Labs, Inc. Announces Public Offering of Common Stock and Pre-Funded Warrants - Quiver Quantitative
Shattuck Labs (NASDAQ: STTK) extends cash runway to 2029 on $54.9M warrant inflow and SL-325 data - Stock Titan
Biotech Shattuck Labs opens stock sale with option for 15% more shares - Stock Titan
Crude Oil Gains Over 1%; Motorcar Parts Of America Shares Surge After Q4 Earnings - Sahm
STTK Maintained by Citigroup -- Price Target Raised to $18.00 - GuruFocus
Shattuck Labs Announces Exercise of Outstanding Common Stock Warrants and Provides Financial Update - Investing News Network
Shattuck Labs receives $54.9M from warrant exercises By Investing.com - Investing.com Nigeria
Shattuck Labs Inc Stock (STTK) Financials Data
Revenue
Net Income
Cash Flow
EPS
Shattuck Labs Inc Stock (STTK) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Shukla Abhinav A. | Chief Technical Officer |
May 12 '26 |
Option Exercise |
3.57 |
2,032 |
7,254 |
83,290 |
| Shukla Abhinav A. | Chief Technical Officer |
May 12 '26 |
Sale |
7.01 |
2,032 |
14,244 |
81,258 |
| Pandite Arundathy N. | Chief Medical Officer |
May 12 '26 |
Sale |
6.61 |
30,000 |
198,300 |
166,219 |
0.40%
0.29%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):